ArticleTrials2022

Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial.

Qi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.